UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060723
Receipt number R000069472
Scientific Title Research on reducing inpatient stress through sound
Date of disclosure of the study information 2026/02/24
Last modified on 2026/02/21 12:01:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on reducing inpatient stress through sound

Acronym

Research on reducing inpatient stress through sound

Scientific Title

Research on reducing inpatient stress through sound

Scientific Title:Acronym

Research on reducing inpatient stress through sound

Region

Japan


Condition

Condition

pregnant women

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

While it is known that playing music for inpatients can lead to a reduction in stress and anxiety, this study aims to clarify the specific characteristics of music that effectively alleviate anxiety.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relationship between musical frequency components and salivary cortisol, heart rate variability (HRV), near-infrared spectroscopy (NIRS) of the epidermis, electroencephalogram (EEG) data, and POMS 2 scores.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Music A will be presented to the participants via either speakers or headphones.

Interventions/Control_2

Music B will be presented to the participants via either speakers or headphones.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

99 years-old >=

Gender

Female

Key inclusion criteria

1 Age 18 years or older at the time of informed consent.

2 Inpatients who have been hospitalized for 5 days or longer.

3 Individuals who have provided voluntary written informed consent after receiving a full explanation and demonstrating sufficient understanding of the study.

Key exclusion criteria

1 Individuals with hearing impairments.

2 Patients with pituitary or adrenal dysfunction, or those currently receiving steroid therapy.

3 Any other individuals judged by the principal investigator to be unsuitable as study participants.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Umazume

Organization

Hokkaido University Hospital

Division name

Obstetrics

Zip code

060-8638

Address

N15W7, Kita-ku, Sapporo, Hokkaido

TEL

011-706-5941

Email

takeuma@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Umazume

Organization

Hokkaido

Division name

Obstetrics

Zip code

060-8638

Address

N15W7, Kita-ku, Sapporo, Hokkaido

TEL

011-706-5941

Homepage URL


Email

takeuma@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board (IRB) of Hokkaido University Hospital

Address

5 Chome, Kita 14-jo Nishi, Kita-ku, Sapporo, Hokkaido

Tel

011-716-1161

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 02 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 02 Month 24 Day

Date of IRB


Anticipated trial start date

2026 Year 03 Month 14 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 02 Month 21 Day

Last modified on

2026 Year 02 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069472